ClinicalTrials.Veeva

Menu

Ovarian Reserve in Diabetes Mellitus

K

Kanuni Sultan Suleyman Training and Research Hospital

Status

Completed

Conditions

Type1 Diabetes Mellitus

Treatments

Other: hormone panel and ultrasonography

Study type

Observational

Funder types

Other

Identifiers

NCT03859856
2018.10.23

Details and patient eligibility

About

Type 1 diabetes mellitus is a common autoimmune disease. It affects women of all ages including reproductive years. Hyperglycemic condition in diabetes can cause organ damage. This study aims to measure serum hormones including FSH, LH, E2, AMH, ovarian volume and antral follicle count (indicators of ovarian reserve) in women with and without type 1 diabetes mellitus.

Full description

Type 1 diabetes mellitus is a common autoimmune disease. It affects women of all ages including reproductive years. It is showed that hyperglycemic state in diabetes results in organ damage like kidneys and eyes. Ovarian reserve is important for the reproductive period. The measurements of serum hormones including follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and anti-mullerian hormone (AMH) will give us an idea about the ovarian reserve. The investigators aim is to measure ovarian reserve parameters in patients diagnosed with type 1 diabetes mellitus and to compare them to healthy controls. Serum FSH, LH, E2 and AMH will be measured on the 3rd day of the cycle. Antral follicle count and ovarian volume measurement will be done with ultrasonography. Ovarian reserve markers will be compared between the groups.

Enrollment

100 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Reproductive age group women: 18-40 years
  • Women diagnosed with type 1 diabetes (case group)
  • Women without type 1 diabetes (control group)

Exclusion criteria

  • Women with PCOS (polycystic ovary syndrome)
  • history of ovarian surgery
  • Body mass index (BMI) over 30

Trial design

100 participants in 2 patient groups

women with Type 1 diabetes mellitus
Description:
Reproductive age women diagnosed with type 1 diabetes mellitus
Treatment:
Other: hormone panel and ultrasonography
women without Type 1 diabetes mellitus
Description:
Reproductive age women diagnosed with type 1 diabetes mellitus to serve as control
Treatment:
Other: hormone panel and ultrasonography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems